학술논문

Non-colorectal liver metastases: A review of interventional and surgical treatment modalities
Document Type
article
Source
Frontiers in Surgery, Vol 9 (2022)
Subject
liver metastases
surgical oncology
interventional radiology
outcome
patient selection
highly specialized centers
Surgery
RD1-811
Language
English
ISSN
2296-875X
Abstract
Liver metastases (LM) occur in up to 90% either simultaneously with the diagnosis of the primary tumor or at a later time-point. While resection of colorectal LM and resection or transplantation of neuroendocrine LM is part of a standard therapy with a 5-year patient survival of up to 80%, resection of non-colorectal and non-neuroendocrine LM is still discussed controversially. The reason for it is the significantly lower survival benefit of all different tumor entities depending on the biological aggressiveness of the tumor. Randomized controlled trials are lacking. However, reviews of case series with ≥100 liver resections are available. They show a 5-year patient survival of up to 42% compared to only